NCT04599010

Brief Summary

Large for Gestational Age (LGA) infants have excess fat-mass (FM) proportion secondary to prolonged in utero exposure to an energy-rich environment. Our preliminary data suggest that excess FM proportion can be associated with oral feeding delay and a potentially modifiable therapeutic target to improve oral feeding outcomes. The objective of this study is to determine the impact of a short-term Fat-free mass (FFM)-indexed feeding on the oral intake volumes in LGA infants with oral feeding difficulties.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
10mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Sep 2024Feb 2027

First Submitted

Initial submission to the registry

October 14, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 22, 2020

Completed
3.9 years until next milestone

Study Start

First participant enrolled

September 26, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2027

Last Updated

May 30, 2025

Status Verified

May 1, 2025

Enrollment Period

1.9 years

First QC Date

October 14, 2020

Last Update Submit

May 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time from study entry to independent oral feeding

    full oral feeding defined as 120 ml/kg/d without tube feeding for 2 consecutive days

    Before or at NICU-discharge

Secondary Outcomes (6)

  • oral feeding volume at NICU discharge

    before 3 months

  • NICU Feeding related length of stay (LOS)

    before 3 months

  • Gastrostomy rates

    through study completion, an average of 1 year

  • ARH levels

    2 weeks

  • Oral feeding success rate

    Before 3 months

  • +1 more secondary outcomes

Study Arms (2)

FFM-indexed feeding

ACTIVE COMPARATOR

In FFM-indexed feeding, there will be a permissive feeding volume restriction to 150 ± 10 mL/kg (FFM)/day without increasing the milk calorie density or changing the type of formula milk for 2 weeks in the intervention group

Other: Dietary intervention

Standard feeding

ACTIVE COMPARATOR

The standard feeding approach will include an oral feeding volume goal of 150 ± 10 mL/kg/day during the 2-week study period

Other: Dietary intervention

Interventions

energy-restricted diet appropriate for resting metabolic rate using FFM as proxy

FFM-indexed feedingStandard feeding

Eligibility Criteria

Age1 Week - 10 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • LGA infants with oral feeding difficulty born at ≥ 35 weeks gestation, with FM z-score \> +1.0 in body composition measurement

You may not qualify if:

  • Infants on any respiratory support, Infants on enteral feeding duration \> 60 minutes due to hypoglycemia concerns, videofluoroscopic swallow study (VFSS) demonstrating unsafe swallowing function, GI surgical conditions, significant neurological morbidities, and major congenital, genetic syndromes/anomalies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Nemours Children's Hospital

Orlando, Florida, 32827, United States

RECRUITING

Emory University

Atlanta, Georgia, 30329, United States

RECRUITING

MeSH Terms

Conditions

Infant Nutrition Disorders

Interventions

Diet Therapy

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeutics

Study Officials

  • Sreekanth Viswanathan, MD

    Nemours Children's Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sreekanth Viswanathan, MD,MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The data analyzer will be masked to the allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The sample size for this pilot study will be 40 with 20 infants randomized into each arm.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Neonatologist, Professor of Pediatrics

Study Record Dates

First Submitted

October 14, 2020

First Posted

October 22, 2020

Study Start

September 26, 2024

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

February 28, 2027

Last Updated

May 30, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data requests can be submitted starting 9 months after article publication
Access Criteria
Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA)

Locations